
Vir Biotechnology Inc
NASDAQ:VIR

Intrinsic Value
The intrinsic value of one
VIR
stock under the Base Case scenario is
1.72
USD.
Compared to the current market price of 5.09 USD,
Vir Biotechnology Inc
is
Overvalued by 66%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Vir Biotechnology Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Vir Biotechnology Inc
Balance Sheet Decomposition
Vir Biotechnology Inc
Current Assets | 932.2m |
Cash & Short-Term Investments | 801.7m |
Other Current Assets | 130.5m |
Non-Current Assets | 375.5m |
Long-Term Investments | 218.1m |
PP&E | 120.2m |
Intangibles | 25m |
Other Non-Current Assets | 12.1m |
Free Cash Flow Analysis
Vir Biotechnology Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Vir Biotechnology Inc
Revenue
|
20.9m
USD
|
Cost of Revenue
|
-786k
USD
|
Gross Profit
|
20.1m
USD
|
Operating Expenses
|
-631.7m
USD
|
Operating Income
|
-611.6m
USD
|
Other Expenses
|
33.9m
USD
|
Net Income
|
-577.6m
USD
|
VIR Profitability Score
Profitability Due Diligence
Vir Biotechnology Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Score
Vir Biotechnology Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
VIR Solvency Score
Solvency Due Diligence
Vir Biotechnology Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Score
Vir Biotechnology Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VIR Price Targets Summary
Vir Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
VIR
is 18.8 USD
with a low forecast of 12.12 USD and a high forecast of 32.55 USD.
Dividends
Current shareholder yield for VIR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VIR
stock under the Base Case scenario is
1.72
USD.
Compared to the current market price of 5.09 USD,
Vir Biotechnology Inc
is
Overvalued by 66%.